Evidence map›Paper›PMID 34407414›Full record

ArticleCell reports2021

Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway.

Rafael Torosyan, Shengping Huang, Prashant V Bommi, Ratnakar Tiwari, Si Young An, Michael Schonfeld, Ganeshkumar Rajendran, Matthew A Kavanaugh, Benjamin Gibbs, Agnieszka D Truax and 7 more

Abstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Elevated brain manganese induces motor disease by upregulating the kynurenine pathway of tryptophan metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Characterizing the metabolic response of the zebrafish kidney to overfeeding.American journal of physiology. Renal physiology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rafael TorosyanThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA.
Shengping HuangThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA.
Prashant V BommiFeinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Ratnakar TiwariFeinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Si Young AnFeinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Michael SchonfeldThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA.
Ganeshkumar RajendranThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA.
Matthew A KavanaughThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA.
Benjamin GibbsThe Jared Grantham Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA.
Agnieszka D TruaxMetabolon, Inc., Durham, NC, USA.
Samuel BohneyMetabolon, Inc., Durham, NC, USA.
M Wade CalcuttVanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Evan W KerrDepartment of Biochemistry, West Virginia University, Morgantown, WV, USA.
Roberta LeonardiDepartment of Biochemistry, West Virginia University, Morgantown, WV, USA.
Peng GaoRobert H. Lurie Cancer Center Metabolomics Core, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Navdeep S ChandelRobert H. Lurie Cancer Center Metabolomics Core, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Medicine and Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Pinelopi P KapitsinouFeinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Medicine and Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Nephrology & Hypertension, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: pinelopi.kapitsinou@northwestern.edu.

Funding

Tissue resident macrophages regulate proteostasis in the aging lungP01AG049665 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GR Scott Budinger · 2015 to 2026
$26.9M
Transgenic and Gener-Targeting CoreP20GM104936 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAADI, IRFAN · 2012 to 2016
$10.9M
Therapeutics Development Core (Core B)P30DK114857 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GEORGE, ALFRED L., QUAGGIN, SUSAN E. · 2018 to 2022
$5.7M
Changes in Coenzyme A Levels are a Key Mechanism Regulating Metabolic PathwaysR35GM119528 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Roberta Leonardi · 2016 to 2026
$4.4M
Endothelial PHD2/HIF Axis in Ischemic Kidney Injury and InflammationR01DK115850 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Pinelopi P. Kapitsinou · 2018 to 2026
$3.5M
University of Kansas Training Grant in NephrologyT32DK071496 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI YU, ALAN S · 2006 to 2016
$1.2M
NIA NIH HHS P01 AG049665NIDDK NIH HHS P30 DK114857NIDDK NIH HHS R01 DK115850NIDDK NIH HHS T32 DK071496NIGMS NIH HHS P20 GM104936NIGMS NIH HHS R35 GM119528
6 · The paper itself

Abstract

Prolonged cellular hypoxia leads to energetic failure and death. However, sublethal hypoxia can trigger an adaptive response called hypoxic preconditioning. While prolyl-hydroxylase (PHD) enzymes and hypoxia-inducible factors (HIFs) have been identified as key elements of oxygen-sensing machinery, the mechanisms by which hypoxic preconditioning protects against insults remain unclear. Here, we perform serum metabolomic profiling to assess alterations induced by two potent cytoprotective approaches, hypoxic preconditioning and pharmacologic PHD inhibition. We discover that both approaches increase serum kynurenine levels and enhance kynurenine biotransformation, leading to preservation of NAD

Indexed as

AnimalsHypoxiaIndoleamine-Pyrrole 2,3,-DioxygenaseInflammationIschemiaKidneyKynurenineMetabolomeMiceMice, Inbred C57BLMice, KnockoutNADProcollagen-Proline DioxygenaseProtective AgentsTryptophanIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenineNADProcollagen-Proline DioxygenaseProtective AgentsTryptophanhypoxiaIDO1ischemia-reperfusionkidneykynurenic acidkynurenineNAD(+)PHDspreconditioning

Identifiers

PMID34407414
PMCPMC8487442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.